Loading clinical trials...
Loading clinical trials...
Garadacimab Real-world Treatment Outcomes of Effectiveness, Safety, and Quality-of-Life in Patients With HAE (GREAT Study)
Conditions
Interventions
No intervention
Locations
18
United States
Medical Research of Arizona
Phoenix, Arizona, United States
Asthma and Allergy Wellness Center
Saint Charles, Illinois, United States
John Hopkins University
Baltimore, Maryland, United States
Washington University
St Louis, Missouri, United States
Riverside Medical Group, Belleville
Belleville, New Jersey, United States
Universitaetsklinikum Ulm
Ulm, Baden-Wurttemberg, Germany
Start Date
July 21, 2025
Primary Completion Date
August 31, 2028
Completion Date
August 31, 2030
Last Updated
March 27, 2026
Lead Sponsor
CSL Behring
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions